Skin microbiota dynamics following B. subtilis formulation challenge: an in vivo study in mice

BMC Microbiol. 2021 Aug 21;21(1):231. doi: 10.1186/s12866-021-02295-y.

Abstract

Background: Modulating the microbiota is a leading-edge strategy for the restoration and maintenance of a healthy, balanced environment. The use of health-promoting bacteria has demonstrated some potential benefits as an alternative for skin microbiota intervention. Here, we investigate the manipulation of mice skin microbiota using B. subtilis incorporated into a supportive Pluronic F-127 hydrogel formulation. The formula plays an important role in delivering the bacteria to the desired action site.

Results: The B. subtilis challenge induced a shift in the composition and abundance of the skin microbiota. Containment of B. subtilis in the Pluronic F-127 hydrogel accelerated bacterial modulation compared with free B. subtilis. The abundance of both Staphylococcus and Corynebacterium spp. was altered as a result of the live bacterial intervention: the abundance of Corynebacterium increased while that of Staphylococcus decreased. Four days after last application of the B. subtilis formulation, B. subtilis counts returned to its initial level.

Conclusions: B. subtilis intervention can induce a shift in the skin microbiota, influencing the abundance of commensal, beneficial, and pathogenic bacteria. Containment of B. subtilis in Pluronic hydrogel accelerates the microbial alteration, probably by facilitating bacterial attachment and supporting continuous growth. Our results reveal the ability of B. subtilis in Pluronic to modulate the skin microbiota composition, suggesting that the formulation holds therapeutic potential for skin disease treatment.

Keywords: Bacillus subtilis; Live bacterial delivery; Microbiota; Pluronic F-127; Skin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bacillus subtilis / drug effects
  • Bacillus subtilis / physiology*
  • Female
  • Mice
  • Mice, Inbred C57BL
  • Microbiota / drug effects*
  • Microbiota / physiology
  • Poloxamer / pharmacology*
  • Skin / drug effects*
  • Skin / microbiology*
  • Skin Diseases, Bacterial / drug therapy
  • Surface-Active Agents / pharmacology*

Substances

  • Surface-Active Agents
  • Poloxamer